Zaleplon (marketed as Sonata) Information

Sonata is used to treat short-term difficulty in falling asleep. Sonata has been shown to decrease the time to sleep onset for up to 30 days in clinical studies. Sonata has not been shown to increase your total sleep time or decrease the number of times you wake up after falling asleep.

• FDA News: FDA Requests Label Change for All Sleep Disorder Drug Products
• Patient Information Sheet

Back to Top     Back to Drug Index

Date created: March 15, 2007

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research